Individualizing surveillance mammography for older breast cancer survivors
Individualizing surveillance mammography for older breast cancer survivors
批准号:
9889945
负责人:
Rachel Ann Freedman
金额:
$19.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-15 至 2021-02-28
关键词:
AddressAgeAttitudeBenefits and RisksBreastBreast Cancer PatientBreast Cancer survivorCancer EtiologyCancer SurvivorCaringCommunicationCommunication ToolsConflict (Psychology)ConsensusDataData CollectionDecision MakingDiagnosisDisciplineDiscipline of NursingFeedbackFocus GroupsGeographyGeriatricsGoalsGuidelinesInterventionIntervention StudiesInterviewKnowledgeLeadLearningLife ExpectancyLongevityMammary Gland ParenchymaMammographic screeningMammographyMissionNational Health Interview SurveyOlder PopulationOncologistOncologyOutcome MeasurePatient advocacyPatientsPerceptionPopulationPractice GuidelinesPrimary Health CareProviderQuality of CareRadiology SpecialtyRandomizedRecommendationRecording of previous eventsRecurrenceResearchResidual stateRiskSideSpecialistStandardizationTelephoneTestingThinkingUnited StatesUnited States National Institutes of HealthVariantWomanWorkagedbasebreast cancer diagnosiscancer recurrencecare coordinationclinical practicecognitive testingevidence basefollow-upimprovedmalignant breast neoplasmmedical specialtiesnovelolder patientolder womenpatient populationpost interventionprospectiverisk minimizationscreeningsurveillance strategysurveillance studytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The long-term goals of this work are to optimize surveillance mammography use for older breast cancer
survivors and decrease overscreening for a group in critical need of evidence-based, unified approaches for
follow-up care. The proposed study will address significant knowledge gaps through expert consensus and
prospective data collection. This study will provide a framework for discussions on how/when to stop
mammography in older breast cancer survivors with limited life expectancy (who typically have a low risk for in-
breast recurrences with rates similar to that of screening populations) and how to optimally discuss life
expectancy with patients, with the goal to enhance communication between patients and clinicians as well as
between primary care clinicians (PCs) and specialists. In this unique, multilevel proposal, we will build on our
prior work to develop consensus on mammography and follow-up care for breast cancer survivors aged ≥75 by
(a) refining expert-panel recommendations, (b) examining clinician and patient attitudes towards these
recommendations and discussing life expectancy, and (c) testing a communication tool to facilitate decision-
making, all through direct engagement of clinicians and patients.
In Aim 1, we will convene experts and patients to refine recommendations for mammography and
follow-up care for breast cancer survivors age ≥75 and further develop and cognitively test a communication
tool that summarizes recommendations for clinicians and patients with a focus on how to comfortably include
conversations on life expectancy comfortably. We will then conduct 30 telephone-based patient interviews and
4-6 focus groups with oncologists and PCs to obtain their opinions about the communication tool, how to
communicate the benefits/risks of mammography, and optimal strategies for discussing life expectancy and
cessation of mammography and coordination of care. In Aim 2, we will test the communication tool with 45
older breast cancer survivors age ≥75 and their oncologists using a pre-post intervention study. Here, we will
examine the feasibility and acceptability of the tool and the effect of using the tool on women's intentions for
mammography. We will also explore communication strategies across medical specialties. We hypothesize
that our communication tool will be feasible, acceptable for patients and providers, and lead to fewer women
intending to receive mammography in the next year. This study will provide preliminary data for a larger pilot
and eventual, prospective, randomized study, with the overarching goal to further assess impact, improve
coordination of care, and disseminate our novel and urgently needed intervention.
The goals of this study are undoubtedly in line with the missions set forth by the NIH and NCI to
address the research gaps in older patients. Further, with approximately 70,000 women age ≥75 per year
diagnosed with breast cancer in the United States and a growing population of older breast cancer patients,
efforts to improve and equalize the quality of follow-up care we deliver will become increasingly important.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: